These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21127480)

  • 1. Profound obesity secondary to hyperphagia in mice lacking kinase suppressor of ras 2.
    Revelli JP; Smith D; Allen J; Jeter-Jones S; Shadoan MK; Desai U; Schneider M; van Sligtenhorst I; Kirkpatrick L; Platt KA; Suwanichkul A; Savelieva K; Gerhardt B; Mitchell J; Syrewicz J; Zambrowicz B; Hamman BD; Vogel P; Powell DR
    Obesity (Silver Spring); 2011 May; 19(5):1010-8. PubMed ID: 21127480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperphagia, not hypometabolism, causes early onset obesity in melanocortin-4 receptor knockout mice.
    Weide K; Christ N; Moar KM; Arens J; Hinney A; Mercer JG; Eiden S; Schmidt I
    Physiol Genomics; 2003 Mar; 13(1):47-56. PubMed ID: 12644632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinase Suppressor of Ras 2 (KSR2) expression in the brain regulates energy balance and glucose homeostasis.
    Guo L; Costanzo-Garvey DL; Smith DR; Neilsen BK; MacDonald RG; Lewis RE
    Mol Metab; 2017 Feb; 6(2):194-205. PubMed ID: 28180061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel black soy peptides with antiobesity effects: activation of leptin-like signaling and AMP-activated protein kinase.
    Jang EH; Moon JS; Ko JH; Ahn CW; Lee HH; Shin JK; Park CS; Kang JH
    Int J Obes (Lond); 2008 Jul; 32(7):1161-70. PubMed ID: 18414417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity.
    Costanzo-Garvey DL; Pfluger PT; Dougherty MK; Stock JL; Boehm M; Chaika O; Fernandez MR; Fisher K; Kortum RL; Hong EG; Jun JY; Ko HJ; Schreiner A; Volle DJ; Treece T; Swift AL; Winer M; Chen D; Wu M; Leon LR; Shaw AS; McNeish J; Kim JK; Morrison DK; Tschöp MH; Lewis RE
    Cell Metab; 2009 Nov; 10(5):366-78. PubMed ID: 19883615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of energy- and nutrient-sensing kinases AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in adipocyte differentiation.
    Fernández-Veledo S; Vázquez-Carballo A; Vila-Bedmar R; Ceperuelo-Mallafré V; Vendrell J
    IUBMB Life; 2013 Jul; 65(7):572-83. PubMed ID: 23671028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinase suppressor of Ras 2 (KSR2) regulates tumor cell transformation via AMPK.
    Fernandez MR; Henry MD; Lewis RE
    Mol Cell Biol; 2012 Sep; 32(18):3718-31. PubMed ID: 22801368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation.
    Pearce LR; Atanassova N; Banton MC; Bottomley B; van der Klaauw AA; Revelli JP; Hendricks A; Keogh JM; Henning E; Doree D; Jeter-Jones S; Garg S; Bochukova EG; Bounds R; Ashford S; Gayton E; Hindmarsh PC; Shield JP; Crowne E; Barford D; Wareham NJ; ; O'Rahilly S; Murphy MP; Powell DR; Barroso I; Farooqi IS
    Cell; 2013 Nov; 155(4):765-77. PubMed ID: 24209692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of
    Gomez GA; Rundle CH; Xing W; Kesavan C; Pourteymoor S; Lewis RE; Powell DR; Mohan S
    Elife; 2022 Nov; 11():. PubMed ID: 36342465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity: the role of hypothalamic AMP-activated protein kinase in body weight regulation.
    Lee WJ; Koh EH; Won JC; Kim MS; Park JY; Lee KU
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2254-9. PubMed ID: 16085448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake.
    Kubota N; Yano W; Kubota T; Yamauchi T; Itoh S; Kumagai H; Kozono H; Takamoto I; Okamoto S; Shiuchi T; Suzuki R; Satoh H; Tsuchida A; Moroi M; Sugi K; Noda T; Ebinuma H; Ueta Y; Kondo T; Araki E; Ezaki O; Nagai R; Tobe K; Terauchi Y; Ueki K; Minokoshi Y; Kadowaki T
    Cell Metab; 2007 Jul; 6(1):55-68. PubMed ID: 17618856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic melanocortin signaling and leptin resistance--perspective of therapeutic application for obesity-diabetes syndrome.
    Masuzaki H; Tanaka T; Ebihara K; Hosoda K; Nakao K
    Peptides; 2009 Jul; 30(7):1383-6. PubMed ID: 19394382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the activities of AMP-activated protein kinase, protein kinase B, and mammalian target of rapamycin by limiting energy availability with 2-deoxyglucose.
    Jiang W; Zhu Z; Thompson HJ
    Mol Carcinog; 2008 Aug; 47(8):616-28. PubMed ID: 18247380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of cardiomyogenesis of embryonic stem cells by nitric oxide downstream of AMP-activated protein kinase and mTOR signaling pathways.
    Padmasekar M; Sharifpanah F; Finkensieper A; Wartenberg M; Sauer H
    Stem Cells Dev; 2011 Dec; 20(12):2163-75. PubMed ID: 21470048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voluntary exercise delays monogenetic obesity and overcomes reproductive dysfunction of the melanocortin-4 receptor knockout mouse.
    Irani BG; Xiang Z; Moore MC; Mandel RJ; Haskell-Luevano C
    Biochem Biophys Res Commun; 2005 Jan; 326(3):638-44. PubMed ID: 15596147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.
    Majumder PK; Febbo PG; Bikoff R; Berger R; Xue Q; McMahon LM; Manola J; Brugarolas J; McDonnell TJ; Golub TR; Loda M; Lane HA; Sellers WR
    Nat Med; 2004 Jun; 10(6):594-601. PubMed ID: 15156201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms.
    Kristof AS; Pacheco-Rodriguez G; Schremmer B; Moss J
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1134-43. PubMed ID: 15923340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mTOR in Glucose and Lipid Metabolism.
    Mao Z; Zhang W
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrient sensor links obesity with diabetes risk.
    Patti ME; Kahn BB
    Nat Med; 2004 Oct; 10(10):1049-50. PubMed ID: 15459705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.